The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Abstract
Addition of chemical tags on the DNA and modification of histone proteins impart a distinct feature on chromatin architecture. With the advancement in scientific research, the key players underlying these changes have been identified as epigenetic modifiers of the chromatin. Indeed, the plethora of enzymes catalyzing these modifications, portray the diversity of epigenetic space and the intricacy in regulating gene expression. These epigenetic players are categorized as writers: that introduce various chemical modifications on DNA and histones, readers: the specialized domain containing proteins that identify and interpret those modifications and erasers: the dedicated group of enzymes proficient in removing these chemical tags. Research over the past few decades has established that these epigenetic tools are associated with numerous disease conditions especially cancer. Besides, with the involvement of epigenetics in cancer, these enzymes and protein domains provide new targets for cancer drug development. This is certain from the volume of epigenetic research conducted in universities and R&D sector of pharmaceutical industry. Here we have highlighted the different types of epigenetic enzymes and protein domains with an emphasis on methylation and acetylation. This review also deals with the recent developments in small molecule inhibitors as potential anti-cancer drugs targeting the epigenetic space.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Datta, J., Ghoshal, K., Denny, W. A., Gamage, S. A., Brooke, D. G., Phiasivongsa, P., Redkar, S., & Jacob, S. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3669 · Cited by 270
RetractedCerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
DNA methylation and its basic function
Moore, L. D., Le, T., & Fan, G. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.112 · Cited by 4,906
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H. F. M., Günther, T., Buettner, R., & Schüle, R. (2005) · Nature · doi:10.1038/nature04020 · Cited by 1,733
Structure and ligand of a histone acetyltransferase bromodomain
Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.-P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Müller, S., Pawson, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,694
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA
Ooi, S. K. T., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage, H., Tempst, P., Lin, S.-P., Allis, C. D., et al. (2007) · Nature · doi:10.1038/nature05987 · Cited by 1,567
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Lyko, F. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.80 · Cited by 1,467
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
JmjC-domain-containing proteins and histone demethylation
Klose, R. J., Kallin, E. M., & Zhang, Y. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1945 · Cited by 1,290
Writing, erasing and reading histone lysine methylations
Hyun, K., Jeon, J., Park, K., & Kim, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.11 · Cited by 1,250
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X.-J., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,230
Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark
Ruthenburg, A. J., Allis, C. D., & Wysocka, J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.014 · Cited by 1,147
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes
Gu, T.-P., Guo, F., Yang, H., Wu, H.-P., Xu, G.-F., Liu, W., Xie, Z.-G., Shi, L., He, X., Jin, S.-G., et al. (2011) · Nature · doi:10.1038/nature10443 · Cited by 1,139
Metabolic regulation of gene expression through histone acylations
Sabari, B. R., Zhang, D., Allis, C. D., & Zhao, Y. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.140 · Cited by 1,130
Bedford, M. T., & Richard, S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.003 · Cited by 1,099
Histone acetyltransferase complexes: one size doesn't fit all
Lee, K. K., & Workman, J. L. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2145 · Cited by 1,087
Protein arginine methyltransferases and cancer
Yang, Y., & Bedford, M. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3409 · Cited by 1,083
Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination
Wang, Y., Wysocka, J., Sayegh, J., Lee, Y.-H., Perlin, J. R., Leonelli, L., Sonbuchner, L. S., McDonald, C. H., Cook, R. G., Dou, Y., et al. (2004) · Science · doi:10.1126/science.1101400 · Cited by 1,010
Understanding the language of Lys36 methylation at histone H3
Wagner, E. J., & Carpenter, P. B. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3274 · Cited by 936
Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.
Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.031 · Cited by 916
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C. L., Dynlacht, B. D., & Reinberg, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.11.004 · Cited by 884
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
Structure and Function of a Human TAF II 250 Double Bromodomain Module
Jacobson, R. H., Ladurner, A. G., King, D. S., & Tjian, R. (2000) · Science · doi:10.1126/science.288.5470.1422 · Cited by 843
Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF
Li, H., Ilin, S., Wang, W., Duncan, E. M., Wysocka, J., Allis, C. D., & Patel, D. J. (2006) · Nature · doi:10.1038/nature04802 · Cited by 814
Vermeulen, M., Eberl, H. C., Matarese, F., Marks, H., Denissov, S., Butter, F., Lee, K. K., Olsen, J. V., Hyman, A. A., Stunnenberg, H. G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.020 · Cited by 806
Wang, H., Huang, Z.-Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P., et al. (2001) · Science · doi:10.1126/science.1060781 · Cited by 805
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1084 · Cited by 776
Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1
Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., & Horio, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609554200 · Cited by 765
JMJD6 Is a Histone Arginine Demethylase
Chang, B., Chen, Y., Zhao, Y., & Bruick, R. K. (2007) · Science · doi:10.1126/science.1145801 · Cited by 745
Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111871200 · Cited by 744
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Basavapathruni, A., Jin, L., Boriack-Sjodin, P. A., Allain, C. J., Klaus, C. R., Raimondi, A., Scott, M. P., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497644 · Cited by 722
Dynamic Regulation of Histone Lysine Methylation by Demethylases
Shi, Y., & Whetstine, J. R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.010 · Cited by 707
Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2
Peña, P. V., Davrazou, F., Shi, X., Walter, K. L., Verkhusha, V. V., Gozani, O., Zhao, R., & Kutateladze, T. G. (2006) · Nature · doi:10.1038/nature04814 · Cited by 684
Bowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.006 · Cited by 666
Readers of histone modifications
Yun, M., Wu, J., Workman, J. L., & Li, B. (2011) · Cell Research · doi:10.1038/cr.2011.42 · Cited by 626
The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3
Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611
Protein Lysine Acetylation by p300/CBP
Dancy, B. M., & Cole, P. A. (2015) · Chemical Reviews · doi:10.1021/cr500452k · Cited by 609
Quenneville, S., Verde, G., Corsinotti, A., Kapopoulou, A., Jakobsson, J., Offner, S., Baglivo, I., Pedone, P. V., Grimaldi, G., Riccio, A., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.032 · Cited by 606
The diverse functions of Dot1 and H3K79 methylation
Nguyen, A. T., & Zhang, Y. (2011) · Genes & Development · doi:10.1101/gad.2057811 · Cited by 597
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Chan-Penebre, E., Kuplast, K. G., Majer, C. R., Boriack-Sjodin, P. A., Wigle, T. J., Johnston, L. D., Rioux, N., Munchhof, M. J., Jin, L., Jacques, S. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1810 · Cited by 569
The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation
Dhayalan, A., Rajavelu, A., Rathert, P., Tamas, R., Jurkowska, R. Z., Ragozin, S., & Jeltsch, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.089433 · Cited by 558
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Qi, W., Chan, H., Teng, L., Li, L., Chuai, S., Zhang, R., Zeng, J., Li, M., Fan, H., Lin, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210371110 · Cited by 547
Balasubramanyam, K., Altaf, M., Varier, R. A., Swaminathan, V., Ravindran, A., Sadhale, P. P., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402839200 · Cited by 546
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
Methyl-cpG-binding domain proteins: readers of the epigenome
Du, Q., Luu, P.-L., Stirzaker, C., & Clark, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.39 · Cited by 544
Cancer biology and NuRD: a multifaceted chromatin remodelling complex
Lai, A. Y., & Wade, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3091 · Cited by 539
Double chromodomains cooperate to recognize the methylated histone H3 tail
Flanagan, J. F., Mi, L.-Z., Chruszcz, M., Cymborowski, M., Clines, K. L., Kim, Y., Minor, W., Rastinejad, F., & Khorasanizadeh, S. (2005) · Nature · doi:10.1038/nature04290 · Cited by 527
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T. J., DiMaggio, P. A., Wasney, G. A., Siarheyeva, A., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.599 · Cited by 527
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive
Guccione, E., Bassi, C., Casadio, F., Martinato, F., Cesaroni, M., Schuchlautz, H., Lüscher, B., & Amati, B. (2007) · Nature · doi:10.1038/nature06166 · Cited by 491
Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1
Avvakumov, G. V., Walker, J. R., Xue, S., Li, Y., Duan, S., Bronner, C., Arrowsmith, C. H., & Dhe-Paganon, S. (2008) · Nature · doi:10.1038/nature07273 · Cited by 489
DNA Methyltransferases: A Novel Target for Prevention and Therapy
Subramaniam, D., Thombre, R., Dhar, A., & Anant, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00080 · Cited by 476
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Konze, K. D., Ma, A., Li, F., Barsyte-Lovejoy, D., Parton, T., MacNevin, C. J., Liu, F., Gao, C., Huang, X.-P., Kuznetsova, E., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400133j · Cited by 452
Recognition of Histone H3 Lysine-4 Methylation by the Double Tudor Domain of JMJD2A
Huang, Y., Fang, J., Bedford, M. T., Zhang, Y., & Xu, R.-M. (2006) · Science · doi:10.1126/science.1125162 · Cited by 446
TRIM24 links a non-canonical histone signature to breast cancer
Tsai, W.-W., Wang, Z., Yiu, T. T., Akdemir, K. C., Xia, W., Winter, S., Tsai, C.-Y., Shi, X., Schwarzer, D., Plunkett, W., et al. (2010) · Nature · doi:10.1038/nature09542 · Cited by 434
The Chd family of chromatin remodelers
Marfella, C. G. A., & Imbalzano, A. N. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.07.012 · Cited by 432
New concepts in DNA methylation
Jeltsch, A., & Jurkowska, R. Z. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.05.002 · Cited by 419
Lorsbach, R. B., Moore, J., Mathew, S., Raimondi, S. C., Mukatira, S. T., & Downing, J. R. (2003) · Leukemia · doi:10.1038/sj.leu.2402834 · Cited by 416
Small-Molecule Inhibition of BRDT for Male Contraception
Matzuk, M. M., McKeown, M. R., Filippakopoulos, P., Li, Q., Ma, L., Agno, J. E., Lemieux, M. E., Picaud, S., Yu, R. N., Qi, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.045 · Cited by 416
Northcott, P. A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.336 · Cited by 412
The methyl-CpG binding domain and the evolving role of DNA methylation in animals
Hendrich, B., & Tweedie, S. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00080-5 · Cited by 399
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
Boyault, C., Sadoul, K., Pabion, M., & Khochbin, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210614 · Cited by 397
Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity
Jorgensen, S., Schotta, G., & Sorensen, C. S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt012 · Cited by 396
Laurent, G., German, N. J., Saha, A. K., de Boer, V. C. J., Davies, M., Koves, T. R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.012 · Cited by 391
AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
Li, Y., Wen, H., Xi, Y., Tanaka, K., Wang, H., Peng, D., Ren, Y., Jin, Q., Dent, S. Y. R., Li, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.049 · Cited by 382
The bromodomain interaction module
Filippakopoulos, P., & Knapp, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.045 · Cited by 374
The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to Transcription
LeRoy, G., Rickards, B., & Flint, S. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.01.018 · Cited by 372
Selective Recognition of Acetylated Histones by Bromodomain Proteins Visualized in Living Cells
Kanno, T., Kanno, Y., Siegel, R. M., Jang, M. K., Lenardo, M. J., & Ozato, K. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00482-9 · Cited by 361
BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
Devaiah, B. N., Case-Borden, C., Gegonne, A., Hsu, C. H., Chen, Q., Meerzaman, D., Dey, A., Ozato, K., & Singer, D. S. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3228 · Cited by 361
A Family of Human Zinc Finger Proteins That Bind Methylated DNA and Repress Transcription
Filion, G. J. P., Zhenilo, S., Salozhin, S., Yamada, D., Prokhortchouk, E., & Defossez, P.-A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.169-181.2006 · Cited by 359
The MYST family of histone acetyltransferases and their intimate links to cancer
Avvakumov, N., & Côté, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210608 · Cited by 353
Recognition of a Mononucleosomal Histone Modification Pattern by BPTF via Multivalent Interactions
Ruthenburg, A. J., Li, H., Milne, T. A., Dewell, S., McGinty, R. K., Yuen, M., Ueberheide, B., Dou, Y., Muir, T. W., Patel, D. J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.053 · Cited by 352
The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier–Gorlin syndrome
Kuo, A. J., Song, J., Cheung, P., Ishibe-Murakami, S., Yamazoe, S., Chen, J. K., Patel, D. J., & Gozani, O. (2012) · Nature · doi:10.1038/nature10956 · Cited by 348
Small Molecule Regulators of Protein Arginine Methyltransferases
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 339
WD40 repeat domain proteins: a novel target class?
Schapira, M., Tyers, M., Torrent, M., & Arrowsmith, C. H. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.179 · Cited by 335
Frankel, A., Yadav, N., Lee, J., Branscombe, T. L., Clarke, S., & Bedford, M. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108786200 · Cited by 334
Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b
Zeng, L., Zhang, Q., Li, S., Plotnikov, A. N., Walsh, M. J., & Zhou, M.-M. (2010) · Nature · doi:10.1038/nature09139 · Cited by 318
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Qi, W., Zhao, K., Gu, J., Huang, Y., Wang, Y., Zhang, H., Zhang, M., Zhang, J., Yu, Z., Li, L., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2304 · Cited by 316
Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.
Villar‐Garea, A., Fraga, M. F., Espada, J., & Esteller, M. (2003) · PubMed · Cited by 316
hMOF Histone Acetyltransferase Is Required for Histone H4 Lysine 16 Acetylation in Mammalian Cells
Taipale, M., Rea, S., Richter, K., Vilar, A., Lichter, P., Imhof, A., & Akhtar, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6798-6810.2005 · Cited by 312
Gowher, H., Liebert, K., Hermann, A., Xu, G., & Jeltsch, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413412200 · Cited by 310
Stec, I., Wright, T. J., van Ommen, G.-J. B., de Boer, P. A. J., van Haeringen, A., Moorman, A. F. M., Altherr, M. R., & den Dunnen, J. T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1071 · Cited by 308
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia
Cao, F., Townsend, E. C., Karatas, H., Xu, J., Li, L., Lee, S., Liu, L., Chen, Y., Ouillette, P., Zhu, J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.001 · Cited by 301
Concise Drug Review: Azacitidine and Decitabine
Derissen, E. J. B., Beijnen, J. H., & Schellens, J. H. M. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0465 · Cited by 299
Inhibitors of Protein Methyltransferases and Demethylases
Kaniskan, H. Ü., Martini, M. L., & Jin, J. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00801 · Cited by 297
Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1
Lee, B. H., Yegnasubramanian, S., Lin, X., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505593200 · Cited by 295
Bromodomain inhibitors and cancer therapy: From structures to applications
Pérez-Salvia, M., & Esteller, M. (2017) · Epigenetics · doi:10.1080/15592294.2016.1265710 · Cited by 292
Li, Y., Trojer, P., Xu, C.-F., Cheung, P., Kuo, A., Drury, W. J., Qiao, Q., Neubert, T. A., Xu, R.-M., Gozani, O., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034462 · Cited by 290
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
Eram, M. S., Shen, Y., Szewczyk, M. M., Wu, H., Senisterra, G., Li, F., Butler, K. V., Kaniskan, H. Ü., Speed, B. A., dela Seña, C., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00839 · Cited by 289
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
Solary, E., Bernard, O. A., Tefferi, A., Fuks, F., & Vainchenker, W. (2014) · Leukemia · doi:10.1038/leu.2013.337 · Cited by 288
A Poised Chromatin Platform for TGF-β Access to Master Regulators
Xi, Q., Wang, Z., Zaromytidou, A.-I., Zhang, X. H.-F., Chow-Tsang, L.-F., Liu, J. X., Kim, H., Barlas, A., Manova-Todorova, K., Kaartinen, V., et al. (2011) · Cell · doi:10.1016/j.cell.2011.11.032 · Cited by 285
Collins, R. E., Northrop, J. P., Horton, J. R., Lee, D. Y., Zhang, X., Stallcup, M. R., & Cheng, X. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1384 · Cited by 284
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Hay, D. A., Fedorov, O., Martin, S., Singleton, D. C., Tallant, C., Wells, C., Picaud, S., Philpott, M., Monteiro, O. P., Rogers, C. M., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412434f · Cited by 277
Krause, C. D., Yang, Z.-H., Kim, Y.-S., Lee, J.-H., Cook, J. R., & Pestka, S. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.06.007 · Cited by 276
Chen, T., Tsujimoto, N., & Li, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9048-9058.2004 · Cited by 273
Jacquet, K., Fradet-Turcotte, A., Avvakumov, N., Lambert, J.-P., Roques, C., Pandita, R. K., Paquet, E., Herst, P., Gingras, A.-C., Pandita, T. K., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.031 · Cited by 263
Brien, G. L., Gambero, G., O'Connell, D. J., Jerman, E., Turner, S. A., Egan, C. M., Dunne, E. J., Jurgens, M. C., Wynne, K., Piao, L., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2449 · Cited by 261
DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination
Qin, W., Wolf, P., Liu, N., Link, S., Smets, M., Mastra, F. L., Forné, I., Pichler, G., Hörl, D., Fellinger, K., et al. (2015) · Cell Research · doi:10.1038/cr.2015.72 · Cited by 258
ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection
Long, H. K., Blackledge, N. P., & Klose, R. J. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130028 · Cited by 250
Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
Rutten, B. P. F., & Mill, J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp104 · Cited by 244
Role of Tet1 in erasure of genomic imprinting
Yamaguchi, S., Shen, L., Liu, Y., Sendler, D., & Zhang, Y. (2013) · Nature · doi:10.1038/nature12805 · Cited by 242
Zurita-Lopez, C. I., Sandberg, T., Kelly, R., & Clarke, S. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336271 · Cited by 242
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression
Yang, X.-J., & Seto, E. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00015-7 · Cited by 241
Epigenetics in cancer: Fundamentals and Beyond
Biswas, S., & Rao, C. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.011 · Cited by 241
Self-citationHistone demethylases in chromatin biology and beyond
Dimitrova, E., Turberfield, A. H., & Klose, R. J. (2015) · EMBO reports · doi:10.15252/embr.201541113 · Cited by 238
Negative regulation of transcription by the type II arginine methyltransferase PRMT5
Fabbrizio, E., Messaoudi, S. E., Polanowska, J., Paul, C., Cook, J. R., Lee, J., Nègre, V., Rousset, M., Pestka, S., Le Cam, A., et al. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf136 · Cited by 237
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
Attar, N., & Kurdistani, S. K. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026534 · Cited by 237
Theodoulou, N. H., Bamborough, P., Bannister, A. J., Becher, I., Bit, R. A., Che, K. H., Chung, C.-W., Dittmann, A., Drewes, G., Drewry, D. H., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00256 · Cited by 235
PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145
Yang, Y., Hadjikyriacou, A., Xia, Z., Gayatri, S., Kim, D., Zurita-Lopez, C., Kelly, R., Guo, A., Li, W., Clarke, S. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms7428 · Cited by 235
Sun, Y., Jiang, X., Chen, S., & Price, B. D. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.092 · Cited by 234
Lipopolysaccharide-induced Methylation of HuR, an mRNA-stabilizing Protein, by CARM1
Li, H., Park, S., Kilburn, B., Jelinek, M. A., Henschen-Edman, A., Aswad, D. W., Stallcup, M. R., & Laird-Offringa, I. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206187200 · Cited by 233
Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes
Ullah, M., Pelletier, N., Xiao, L., Zhao, S. P., Wang, K., Degerny, C., Tahmasebi, S., Cayrou, C., Doyon, Y., Goh, S.-L., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01297-08 · Cited by 233
Wolf, S. S. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0010-x · Cited by 232
Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology
York, B., & O'Malley, B. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.193367 · Cited by 230
The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
He, Y., Selvaraju, S., Curtin, M. L., Jakob, C. G., Zhu, H., Comess, K. M., Shaw, B., The, J., Lima-Fernandes, E., Szewczyk, M. M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2306 · Cited by 224
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Martin, L. J., Koegl, M., Bader, G., Cockcroft, X.-L., Fedorov, O., Fiegen, D., Gerstberger, T., Hofmann, M. H., Hohmann, A. F., Kessler, D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01865 · Cited by 224
Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity
Stimson, L., Rowlands, M. G., Newbatt, Y. M., Smith, N. F., Raynaud, F. I., Rogers, P., Bavetsias, V., Gorsuch, S., Jarman, M., Bannister, A., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0135 · Cited by 223
Predictive chromatin signatures in the mammalian genome
Hon, G. C., Hawkins, R. D., & Ren, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp409 · Cited by 222
Human UTY(KDM6C) Is a Male-specific Nϵ-Methyl Lysyl Demethylase
Walport, L. J., Hopkinson, R. J., Vollmar, M., Madden, S. K., Gileadi, C., Oppermann, U., Schofield, C. J., & Johansson, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555052 · Cited by 219
LSD1: Biologic Roles and Therapeutic Targeting
Maiques-Diaz, A., & Somervaille, T. C. (2016) · Epigenomics · doi:10.2217/epi-2016-0009 · Cited by 204
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203
PRMT7, a New Protein Arginine Methyltransferase That Synthesizes Symmetric Dimethylarginine
Lee, J.-H., Cook, J. R., Yang, Z.-H., Mirochnitchenko, O., Gunderson, S. I., Felix, A. M., Herth, N., Hoffmann, R., & Pestka, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405295200 · Cited by 197
Hsia, D. A., Tepper, C. G., Pochampalli, M. R., Hsia, E. Y. C., Izumiya, C., Huerta, S. B., Wright, M. E., Chen, H.-W., Kung, H.-J., & Izumiya, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000401107 · Cited by 195
The control of histone lysine methylation in epigenetic regulation
Völkel, P., & Angrand, P.-O. (2007) · Biochimie · doi:10.1016/j.biochi.2006.07.009 · Cited by 195
Mechanisms of human histone and nucleic acid demethylases
Walport, L. J., Hopkinson, R. J., & Schofield, C. J. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.09.015 · Cited by 193
Targeting histone lysine demethylases — Progress, challenges, and the future
Thinnes, C. C., England, K. S., Kawamura, A., Chowdhury, R., Schofield, C. J., & Hopkinson, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.009 · Cited by 192
Miranda, T. B., Miranda, M., Frankel, A., & Clarke, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312904200 · Cited by 192
Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1
Musselman, C. A., Avvakumov, N., Watanabe, R., Abraham, C. G., Lalonde, M.-E., Hong, Z., Allen, C., Roy, S., Nuñez, J. K., Nickoloff, J., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2435 · Cited by 189
Kuck, D., Caulfield, T., Lyko, F., & Medina-Franco, J. L. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0609 · Cited by 188
Recent Progress in Histone Demethylase Inhibitors
McAllister, T. E., England, K. S., Hopkinson, R. J., Brennan, P. E., Kawamura, A., & Schofield, C. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01758 · Cited by 186
Bonday, Z. Q., Cortez, G. S., Grogan, M. J., Antonysamy, S., Weichert, K., Bocchinfuso, W. P., Li, F., Kennedy, S., Li, B., Mader, M. M., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00014 · Cited by 183
Tong, J. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1114 · Cited by 181
Mbd1 Is Recruited to both Methylated and Nonmethylated CpGs via Distinct DNA Binding Domains
Jørgensen, H. F., Ben-Porath, I., & Bird, A. P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3387-3395.2004 · Cited by 177
Kuntz, K. W., Campbell, J. E., Keilhack, H., Pollock, R. M., Knutson, S. K., Porter-Scott, M., Richon, V. M., Sneeringer, C. J., Wigle, T. J., Allain, C. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01501 · Cited by 175
Caron, C., Lestrat, C., Marsal, S., Escoffier, E., Curtet, S., Virolle, V, Barbry, P., Debernardi, A., Brambilla, C., Brambilla, E., et al. (2010) · Oncogene · doi:10.1038/onc.2010.259 · Cited by 173
The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9
Dhayalan, A., Tamas, R., Bock, I., Tattermusch, A., Dimitrova, E., Kudithipudi, S., Ragozin, S., & Jeltsch, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr107 · Cited by 170
Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain
James, L. I., Barsyte-Lovejoy, D., Zhong, N., Krichevsky, L., Korboukh, V. K., Herold, J. M., MacNevin, C. J., Norris, J. L., Sagum, C. A., Tempel, W., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1157 · Cited by 169
Sirtuin Inhibitors as Anticancer Agents
Hu, J., Jing, H., & Lin, H. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.44 · Cited by 169
Hopkinson, R. J., Tumber, A., Yapp, C., Chowdhury, R., Aik, W., Che, K. H., Li, X. S., Kristensen, J. B. L., King, O. N. F., Chan, M. C., et al. (2013) · Chemical Science · doi:10.1039/c3sc51122g · Cited by 164
Preferential Methylation of Unmethylated DNA by Mammalian de Novo DNA Methyltransferase Dnmt3a
Yokochi, T., & Robertson, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106590200 · Cited by 161
Biel, M., Kretsovali, A., Karatzali, E., Papamatheakis, J. D., & Giannis, A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200453879 · Cited by 161
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
Nakayama, K., Szewczyk, M. M., Seña, C. D., Wu, H., Dong, A., Zeng, H., Li, F., de Freitas, R. F., Eram, M. S., Schapira, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24883 · Cited by 158
Drew, A. E., Moradei, O. M., Jacques, S. L., Rioux, N., Boriack-Sjodin, A., Allain, C. J., Scott, M. P., Jin, L., Raimondi, A., Handler, J. L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18446-z · Cited by 155
Berenguer‐Daizé, C., Astorgues‐Xerri, L., Odore, E., Cayol, M., Cvitkovic, E., Noel, K., Békradda, M., MacKenzie, S., Rezaï, K., Lokiec, F. M., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30256 · Cited by 149
Kanıskan, H. Ü., Szewczyk, M. M., Yu, Z., Eram, M. S., Yang, X., Schmidt, K. T., Luo, X., Dai, M., He, F., Zang, I., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412154 · Cited by 148
Trievel, R. C., & Shilatifard, A. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0709-678 · Cited by 146
Sachchidanand, Resnick‐Silverman, L., Yan, S. X., Mutjaba, S., Liu, W., Zeng, L., Manfredi, J. J., & Zhou, M. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.10.014 · Cited by 145
Lacroix, M., Messaoudi, S. E., Rodier, G., Cam, A. L., Sardet, C., & Fabbrizio, E. (2008) · EMBO Reports · doi:10.1038/embor.2008.45 · Cited by 145
MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease
Yang, X. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.014 · Cited by 141
Guan, X., Xu, J., Anzick, S. L., Zhang, H., Trent, J. M., & Meltzer, P. S. (1996) · PubMed · Cited by 139
Cheng, J., Yang, Y., Fang, J., Xiao, J., Zhu, T., Chen, F., Wang, P., Li, Z., Yang, H., & Xu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415398 · Cited by 139
YEATS Domain—A Histone Acylation Reader in Health and Disease
Zhao, D. Y., Li, Y., Xiong, X., Chen, Z., & Li, H. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.010 · Cited by 139
Revenko, A. S., Kalashnikova, E. V., Gemo, A. T., Zou, J. X., & Chen, H.-W. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-10 · Cited by 138
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
Nguyen, H., Allali‐Hassani, A., Antonysamy, S., Chang, S. S., Chen, L. H., Curtis, C., Emtage, S., Li, F., Gheyi, T., Li, F., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.626861 · Cited by 137
Willmann, D., Lim, S., Wetzel, S., Metzger, E., Jandausch, A., Wilk, W., Jung, M., Forné, I., Imhof, A., Janzer, A., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27555 · Cited by 135
Wang, J., Kim, T. H., Ahn, M. Y., Lee, J., Jung, J. H., Choi, W. S., Lee, B. M., YOON, K. S., Yoon, S., & Kim, H. S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1534 · Cited by 134
Qiu, Y., Liu, L., Zhao, C., Han, C., Li, F., Zhang, J., Wang, Y., Li, G., Mei, Y., Wu, M., et al. (2012) · Genes & Development · doi:10.1101/gad.188359.112 · Cited by 134
Tennen, R. I., Berber, E., & Chua, K. F. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.01.006 · Cited by 133
6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site
Ghizzoni, M., Wu, J., Gao, T., Haisma, H. J., Dekker, F. J., & Zheng, Y. G. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.001 · Cited by 133
Small-Molecule Modulators of Methyl-Lysine Binding for the CBX7 Chromodomain
Ren, C., Morohashi, K., Plotnikov, A. N., Jakoncic, J., Smith, S. G., Li, J., Zeng, L., Rodríguez, Y., Stojanoff, V., Walsh, M. J., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.11.021 · Cited by 131
Histone H3 Lysine 56 Methylation Regulates DNA Replication through Its Interaction with PCNA
Yu, Y., Song, C., Zhang, Q., DiMaggio, P. A., Garcia, B. A., York, A. G., Carey, M., & Grunstein, M. R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.019 · Cited by 130
Chantalat, S., Depaux, A., Héry, P., Barral, S., Thuret, J., Dimitrov, S. I., & Gérard, M. (2011) · Genome Research · doi:10.1101/gr.118091.110 · Cited by 129
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
Gajer, J. M., Furdas, S. D., Gründer, A., Gothwal, M., Heinicke, U., Keller, K., Colland, F., Fulda, S., Pahl, H. L., Fichtner, I., et al. (2015) · Oncogenesis · doi:10.1038/oncsis.2014.51 · Cited by 128
Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.
Labbe, R. M., Holowatyj, A., & Yang, Z.-Q. (2013) · Europe PMC (PubMed Central) · Cited by 127
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis
Clocchiatti, A., Florean, C., & Brancolini, C. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01321.x · Cited by 127
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
Li, L. X., Fan, L. X., Zhou, J. X., Grantham, J. J., Calvet, J. P., Sage, J., & Li, X. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90921 · Cited by 127
Sequence-specific recognition of methylated DNA by human zinc-finger proteins
Sasai, N., Nakao, M., & Defossez, P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq280 · Cited by 125
Rational design and validation of a Tip60 histone acetyltransferase inhibitor
Gao, C., Bourke, E., Scobie, M., Famme, M. A., Koolmeister, T., Helleday, T., Eriksson, L. A., Lowndes, N. F., & Brown, J. A. L. (2014) · Scientific Reports · doi:10.1038/srep05372 · Cited by 118
Gu, B., & Lee, M. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-39 · Cited by 115
Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin
Hansen, J. C., Ghosh, R. P., & Woodcock, C. L. F. (2010) · IUBMB Life · doi:10.1002/iub.386 · Cited by 114
Keeping it in the family: diverse histone recognition by conserved structural folds
Yap, K. L., & Zhou, M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.512001 · Cited by 113
Sadakierska−Chudy, A., Kostrzewa, R. M., & Filip, M. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9497-5 · Cited by 111
Lamin B Receptor Recognizes Specific Modifications of Histone H4 in Heterochromatin Formation
Hirano, Y., Hizume, K., Kimura, H., Takeyasu, K., Haraguchi, T., & Hiraoka, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397950 · Cited by 111
The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA
Laget, S., Joulie, M., Le Masson, F., Sasai, N., Christians, E., Pradhan, S., Roberts, R. J., & Defossez, P.-A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011982 · Cited by 110
A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1
Prusevich, P., Kalin, J. H., Ming, S. A., Basso, M., Givens, J., Li, X., Hu, J., Taylor, M. S., Cieniewicz, A. M., Hsiao, P.-Y., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500018s · Cited by 109
Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells
Yuan, Y., Aj, T., Castoreno, A. B., Kuo, S.-Y., Wang, Q., Kuballa, P., Xavier, R. J., Shamji, A. F., Schreiber, S. L., & Bk, W. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.191 · Cited by 108
Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
Yan, L., Yan, C., Qian, K., Su, H., Kofsky-Wofford, S. A., Lee, W.-C., Zhao, X., Ho, M., Ivanov, I. N., & Zheng, Y. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401884z · Cited by 106
Kang, J., Kim, J., Kim, K., Park, J. W., Cho, H., Hahm, J. Y., Chae, Y., Kim, D., Kook, H. Y., Rhee, S., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800242r · Cited by 105
Meyer, R., Wolf, S. S., & Obendorf, M. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.006 · Cited by 100
Identification and Characterization of Small Molecule Inhibitors of a Plant Homeodomain Finger
Wagner, E. K., Nath, N., Flemming, R., Feltenberger, J. B., & Denu, J. M. (2012) · Biochemistry · doi:10.1021/bi3009278 · Cited by 99
Pappano, W. N., Guo, J. Q., He, Y., Ferguson, D. C., Jagadeeswaran, S., Osterling, D. J., Gao, W., Spence, J. K., Pliushchev, M. A., Sweis, R. F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131716 · Cited by 99
NAD+-dependent histone deacetylases (sirtuins) as novel therapeutic targets
Schemies, J., Uciechowska, U., Sippl, W., & Jung, M. (2009) · Medicinal Research Reviews · doi:10.1002/med.20178 · Cited by 98
Nucleolar protein Spindlin1 recognizes H3K4 methylation and stimulates the expression of rRNA genes
Wang, W., Chen, Z., Mao, Z., Zhang, H., Ding, X., Chen, S., Zhang, X., Xu, R.-M., & Zhu, B. (2011) · EMBO Reports · doi:10.1038/embor.2011.184 · Cited by 98
Shen, Y., Szewczyk, M. M., Eram, M. S., Smil, D. V., Kanıskan, H. Ü., de Freitas, R. F., Senisterra, G. A., Li, F., Schapira, M., Brown, P. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01033 · Cited by 98
Histone acetyltransferase 1: More than just an enzyme?
Parthun, M. R. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.07.006 · Cited by 96
Lai, Y.-S., Chen, J.-Y., Tsai, H.-J., Chen, T. Y., & Hung, W. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.37 · Cited by 95
Cited by
The timeline of epigenetic drug discovery: from reality to dreams
Ganesan, A., Arimondo, P. B., Rots, M. G., Jeronimo, C., & Berdasco, M. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0776-0 · Cited by 341
Epigenetics in hepatocellular carcinoma
Nagaraju, G. P., Dariya, B., Kasa, P., Peela, S., & El-Rayes, B. F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.017 · Cited by 339
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
Yu, X., Zhao, H., Wang, R., Chen, Y., Ouyang, X., Li, W., Sun, Y., & Peng, A. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01803-z · Cited by 287
Liu, R., Wu, J., Guo, H., Yao, W., Li, S., Lu, Y., Jia, Y., Liang, X., Tang, J., & Zhang, H. (2023) · MedComm · doi:10.1002/mco2.292 · Cited by 264
The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases
Todd, A. C., & Hardingham, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249607 · Cited by 172
Metadata
- Authors
- Biswas, S., & Rao, C. M.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 837
- Pages
- 8-24
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2887245558
- Cited by
- 389
- References
- 240
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.